JP2000506005A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000506005A5 JP2000506005A5 JP1997530180A JP53018097A JP2000506005A5 JP 2000506005 A5 JP2000506005 A5 JP 2000506005A5 JP 1997530180 A JP1997530180 A JP 1997530180A JP 53018097 A JP53018097 A JP 53018097A JP 2000506005 A5 JP2000506005 A5 JP 2000506005A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/604,333 | 1996-02-21 | ||
| US08/604,333 US5776731A (en) | 1996-02-21 | 1996-02-21 | DNA encoding type-I interleukin-I receptor-like protein designated 2F1 |
| PCT/US1997/001697 WO1997031010A1 (en) | 1996-02-21 | 1997-02-06 | Receptor protein designated 2f1 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000506005A JP2000506005A (ja) | 2000-05-23 |
| JP2000506005A5 true JP2000506005A5 (2) | 2005-03-10 |
| JP4082733B2 JP4082733B2 (ja) | 2008-04-30 |
Family
ID=24419190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53018097A Expired - Fee Related JP4082733B2 (ja) | 1996-02-21 | 1997-02-06 | ２ｆ１と呼ばれる受容体タンパク質 |
Country Status (12)
| Country | Link |
|---|---|
| US (8) | US5776731A (2) |
| EP (1) | EP1007537B1 (2) |
| JP (1) | JP4082733B2 (2) |
| AT (1) | ATE368682T1 (2) |
| AU (1) | AU720943B2 (2) |
| CA (1) | CA2245496C (2) |
| DE (2) | DE69737978T2 (2) |
| DK (1) | DK1007537T3 (2) |
| ES (1) | ES2287950T3 (2) |
| NZ (1) | NZ331176A (2) |
| PT (1) | PT1007537E (2) |
| WO (1) | WO1997031010A1 (2) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776731A (en) * | 1996-02-21 | 1998-07-07 | Immunex Corporation | DNA encoding type-I interleukin-I receptor-like protein designated 2F1 |
| JP4024366B2 (ja) * | 1996-11-29 | 2007-12-19 | 株式会社林原生物化学研究所 | ポリペプチド |
| US7141393B2 (en) * | 1996-12-26 | 2006-11-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18-receptor proteins |
| JP3955352B2 (ja) | 1997-02-25 | 2007-08-08 | 株式会社林原生物化学研究所 | 破骨細胞形成阻害剤 |
| US6087116A (en) * | 1997-03-12 | 2000-07-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18 (IL-18) receptor polypeptides and their uses |
| JP2002514079A (ja) * | 1997-05-01 | 2002-05-14 | アムジエン・インコーポレーテツド | キメラｏｐｇポリペプチド |
| US7393663B2 (en) * | 1997-08-01 | 2008-07-01 | Serono Genetics Institute S.A. | Expressed sequence tags and encoded human proteins |
| US7704944B2 (en) * | 1997-08-14 | 2010-04-27 | Yeda Research And Development Company Ltd. | Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis |
| IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
| US7220717B2 (en) * | 1997-08-14 | 2007-05-22 | Yeda Research And Development Company Ltd. | Interleukin-18 binding proteins, their preparation and use |
| US6326472B1 (en) * | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
| EP1047781B1 (en) | 1998-01-23 | 2004-07-28 | Immunex Corporation | Il-18 receptors |
| CA2276216A1 (en) * | 1998-06-24 | 1999-12-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | An artificial peptide capable of neutralizing the biological activity of interleukin-18 |
| US7029861B1 (en) | 1998-09-15 | 2006-04-18 | Board Of Regents, The University Of Texas System | LPS-response gene compositions and methods |
| US6472179B2 (en) * | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| US6899869B2 (en) * | 2000-04-25 | 2005-05-31 | Tomoaki Hoshino | Method of preparing an animal model for interstitial pneumonia |
| US20010053764A1 (en) * | 2000-05-12 | 2001-12-20 | Sims John E. | Interleukin-1 inhibitors in the treatment of diseases |
| AU2002224417A1 (en) * | 2000-10-18 | 2002-04-29 | Immunex Corporation | Methods for treating il-18 mediated disorders |
| JP4696382B2 (ja) * | 2001-03-21 | 2011-06-08 | アイシン精機株式会社 | 三本鎖ｄｎａの形成方法 |
| SI1485477T1 (sl) * | 2002-02-25 | 2009-10-31 | Genentech Inc | Novi citokinski receptor GLM-R tipa 1 |
| AU2003259995B2 (en) | 2002-08-28 | 2009-07-02 | Immunex Corporation | Compositions and methods for treating cardiovascular disease |
| US7887802B2 (en) | 2004-07-16 | 2011-02-15 | Atsuo Sekiyama | IL-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| AU2011226823B2 (en) * | 2004-07-16 | 2012-09-20 | Atsuo Sekiyama | IL-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| JP2009527535A (ja) * | 2006-02-22 | 2009-07-30 | ユニバーシティ オブ チューリッヒ | 自己免疫疾患又は脱髄疾患を処置するための可溶性受容体及び方法 |
| CL2008002153A1 (es) * | 2007-07-24 | 2009-06-05 | Amgen Inc | Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r. |
| EP2744489A4 (en) | 2011-08-15 | 2015-03-18 | Abbott Lab | PROCESS FOR THE PREPARATION OF HMB AND SALTS FROM THEREOF |
| KR20210130168A (ko) * | 2019-02-08 | 2021-10-29 | 세다르스-신나이 메디칼 센터 | Il18r1을 표적화하는 염증성 질환의 치료를 위한 방법, 시스템 및 키트 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989004838A1 (en) * | 1987-11-25 | 1989-06-01 | Immunex Corporation | Interleukin-1 receptors |
| US5853721A (en) * | 1995-01-31 | 1998-12-29 | Hoffmann-La Roche Inc. | Antibody to interleukin-12 receptor |
| US5776731A (en) * | 1996-02-21 | 1998-07-07 | Immunex Corporation | DNA encoding type-I interleukin-I receptor-like protein designated 2F1 |
| US6326472B1 (en) * | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
-
1996
- 1996-02-21 US US08/604,333 patent/US5776731A/en not_active Expired - Lifetime
-
1997
- 1997-02-06 CA CA2245496A patent/CA2245496C/en not_active Expired - Fee Related
- 1997-02-06 AU AU22553/97A patent/AU720943B2/en not_active Ceased
- 1997-02-06 JP JP53018097A patent/JP4082733B2/ja not_active Expired - Fee Related
- 1997-02-06 PT PT97905729T patent/PT1007537E/pt unknown
- 1997-02-06 DE DE69737978T patent/DE69737978T2/de not_active Expired - Lifetime
- 1997-02-06 NZ NZ331176A patent/NZ331176A/xx not_active IP Right Cessation
- 1997-02-06 AT AT97905729T patent/ATE368682T1/de active
- 1997-02-06 DK DK97905729T patent/DK1007537T3/da active
- 1997-02-06 DE DE97905729T patent/DE97905729T1/de active Pending
- 1997-02-06 ES ES97905729T patent/ES2287950T3/es not_active Expired - Lifetime
- 1997-02-06 EP EP97905729A patent/EP1007537B1/en not_active Expired - Lifetime
- 1997-02-06 WO PCT/US1997/001697 patent/WO1997031010A1/en not_active Ceased
-
1998
- 1998-07-06 US US09/110,618 patent/US6090918A/en not_active Expired - Lifetime
-
2000
- 2000-05-24 US US09/578,178 patent/US6451760B1/en not_active Expired - Fee Related
- 2000-05-24 US US09/577,806 patent/US6492496B1/en not_active Expired - Fee Related
-
2002
- 2002-05-28 US US10/157,447 patent/US7001599B2/en not_active Expired - Fee Related
-
2004
- 2004-05-28 US US10/857,664 patent/US7235238B2/en not_active Expired - Fee Related
-
2007
- 2007-06-25 US US11/768,156 patent/US7625710B2/en not_active Expired - Fee Related
-
2009
- 2009-10-22 US US12/604,289 patent/US8034343B2/en not_active Expired - Fee Related